Herpes Simplex Virus II (HSV II, Herpes Simplex Virus 2, HSV2)

Catalog No : USB-H2033-30H
431.05€
0.00€

Shipping cost plus VAT not included , delivery in 7-14 business days

Product name Herpes Simplex Virus II (HSV II, Herpes Simplex Virus 2, HSV2)
Catalog No USB-H2033-30H
Supplier’s Catalog No H2033-30H
Supplier US Biologicals
Source antigen Herpes simplex virus 2, MS strain, cultured in BSC-1, a cell line derived from African Green monkey kidney.
Reactivity
Cross reactivity
Applications
Molecular weight
Storage -70°C
Other names
Grade Inactivated Pathogen
Purity
Form Supplied as a liquid in Tissue culture medium. Preservative free.
Reactivity life 12 months
Note For reserch purpose only
Purity
Description Herpes simplex virus 2 (HSV-2) belongs to Herpesviridae, a family of viruses with several members that invade the human nervous system, causing a variety of illnesses including cold sores, chickenpox, shingles and various cancers. Herpes viruses may also cause encephalitis or infectious corneal blindness. HSV is transmitted during close contact with an infected person who is shedding virus from the skin, in saliva or in secretions from the genitals and commonly persists in latent infection. PIP010 contains a high concentration of virus particles and components in tissue culture medium contianing a low concentration of bovine serum. Some residual host cellular material is present. Source: Viral Herpes simplex 2, MS strain, cultured in BSC-1, a cell line derived from African Green monkey kidney. Activity: Rendered inactive by standard procedures. However this material should still be handled as infectious and should be disposed of appropriately. Applications: Suitable for use in ELISA. Other applications not tested. Recommended Dilution: Optimal dilutions to be determined by the researcher. Storage and Stability: May be stored at 4°C for short-term only. For long-term storage, aliquot and store at -20°C. Aliquots are stable for at least 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.